The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
NCT Number: NCT03462277
The purpose of this trial is to investigate the relationship between DNA methylation and hydroxymethylation and the expression of DNMTs, TET family gene and the degree of coronary heart disease.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Chongqing, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Male and Female. Patients older than 65 years old who are willing to participate in the study. CHD patients was defined as at least one lesion in a coronary artery or branches in coronary angiograms. Control group was defined as people with negative findings in coronary angiograms.
Exclusion criteria
Patients with concurrent infection or any documented inflammatory illness, such as arthritis or connective tissue diseases, or any other malignancy. Patients with a history of cardiomyopathy. Pregnant women. Severe hepatic dysfunction or End-stage renal failure. Uncontrolled hypertension.
Time frame: 1 month
Collection of blood samples and measuring the samples by PCR and ELISA
Chongqing Medical University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00651274
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05271591
Arterial Occlusive Diseases, Arteriosclerosis
Ajax, Ontario, Canada
View Trial DetailsNCT02119767
Arterial Occlusive Diseases, Arteriosclerosis
Papworth Everard, Cambridgeshire, United Kingdom
View Trial DetailsNCT00568594
Arterial Occlusive Diseases, Arteriosclerosis
Philadelphia, Pennsylvania, United States
View Trial Details